|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/72 | (2006.01) |
| A61K 31/46 | (2006.01) |
| (11) | Number of the document | 1492513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03745193.7 |
| Date of filing the European patent application | 2003-03-20 | |
| (97) | Date of publication of the European application | 2005-01-05 |
| (45) | Date of publication and mention of the grant of the patent | 2006-09-20 |
| (46) | Date of publication of the claims translation | 2007-01-25 |
| (86) | Number | PCT/EP2003/002898 |
| Date | 2003-03-20 |
| (87) | Number | WO 2003/082252 |
| Date | 2003-10-09 |
| (30) | Number | Date | Country code |
| 10214263 | 2002-03-28 | DE |
| (72) |
SCHMELZER, Christel, DE
|
| (73) |
Boehringer Ingelheim Pharma GmbH & Co.KG,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | HFA-suspensinės kompozicijos, turinčios priešcholinerginio agento |
| HFA-SUSPENSION FORMULATIONS CONTAINING AN ANTICHOLINERGIC |
| Payment date | Validity (years) | Amount | |
| 2021-02-18 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-03-20 |